1Panganamala RV, Karpen CW, Merola AJ.Peroxide mediated effects of homocysteeine on arterial prostacyclin synthesis[J].Prostaglandins Leukot, 1986,22: 349 - 356.
2Jacobsen DW, Poddar R. Vascular dysfunction at the cellar level[J]. Neth J Med, 1998,52(suppl):S1.Abstract.
3Dudman NP, Temple SE, Guo XW, et al. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo[J]. Circ Res, 1999, 84(4) : 409 -416.
4Fryer RH, Wilson BD, Gubler DB, et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells[J]. Arteriosscler Thromb, 1993, 13(9): 1327-1333.
5Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular end othelial cell activator[ J].J Clin Invest, 1986, 77(6) : 1909 - 1916.
6Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombagenic agent, suppresses anticoagulant hetxaran sulfate exprecision in cultured porcine aortic endothelial cells[J]. J Clin Invest, 1993, 92(3): 1381 - 1386.
7Hayashi T, Honda G, Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells[J]. Blood, 1992, 79(11) : 2930 - 2936.
8Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis[J]. J Nutr, 1996, 126(4): 1285S- 1289S.
9Midorikawa S, Sanaa H, Hashimoto S, et al. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells[ J]. Bioehem-Biophys-Res-Commun, 2000, 272 ( 1 ) :182 - 185.
10Naurath HJ, Joosten E, Riezler R, et al,. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentmtions[J]. Lancet, 1995,346(8967) : 85-89.
